SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-172060
Filing Date
2022-06-10
Accepted
2022-06-10 17:01:03
Documents
12
Period of Report
2022-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d331287d8k.htm   iXBRL 8-K 44027
  Complete submission text file 0001193125-22-172060.txt   166406

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crtx-20220608.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20220608_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20220608_pre.xml EX-101.PRE 10818
6 EXTRACTED XBRL INSTANCE DOCUMENT d331287d8k_htm.xml XML 3231
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 221009718
SIC: 2836 Biological Products, (No Diagnostic Substances)